News and Media
;
Largest study of its kind informs treatment of breast cancer in men
Commonly used recurrence risk tests found to be useful for male patients Breast cancer is usually thought of as a disease that affects women, but many are not aware that men can develop breast cancer as well. Two-hundred and forty men in Canada were diagnosed with the disease in 2020 and it is estimated that […]
Read the story
Sep 07, 2021
Clinical trial breaks new ground on using immunotherapy for more cancer types
Aug 17, 2021
Researchers uncover evolutionary forces at play in the aging of the blood system and identify people at increased risk of blood cancer
Jul 13, 2021
Microscopes and molecules: New OICR Investigator Dr. Rola Saleeb brings integrated approach to cancer pathology
Jul 06, 2021
Learning how to fly blind
Jun 11, 2021
Unravelling the secrets of the non-coding cancer genome
Jun 09, 2021
New OICR Investigator aims to improve cancer treatment in Ontario and worldwide
Recent Videos
Media Contact
Resources
OICR Brand Guidelines
Jul 28, 2021
Download the OICR brand guidelines.
News Releases
Aug 17, 2021
Researchers uncover evolutionary forces at play in the aging of the blood system and identify people at increased risk of blood cancer
Feb 04, 2021
Clinical trial: Using MRI for prostate cancer diagnosis equals or beats current standard
Jun 25, 2020
CanPath Awarded $2.1 million CIHR Grant for SUPPORT-Canada COVID-19 Initiative
@OICR_News on Twitter
With the help of host institution & funder, @OICR_news, we are able to create a ‘universal common genomics language’. OICR President & Scientific Director @RadvanyiLaszlo mentions this is key to solving today’s global health challenges.
Cancer research news roundup for the week of September 13 - 17, 2021: http://ow.ly/ORZg50Gc6Yh
#cancerresearch #cancernews
The @GA4GH #9thPlenary is September 28-29. The event will bring together the genomics and health community for two days of keynotes, talks, updates and workshops that will focus on advancing genomic data sharing standards. Register: http://ow.ly/v2et50GbekT
Early bird registration is now open for the #CCRAconf hosted by @CCRAlliance. Register today for discounted pricing on registration.
Registration - CCRA
ow.ly
Are you a creative storyteller with experience working in research, health or life sciences communications? Join our team as a Senior Communications Officer. Apply today: http://ow.ly/W6KY50GbdfB #jobs #careers #hiring
Cancer research news roundup for the week of September 6 - 10, 2021: http://ow.ly/s1Cb50G7Yiw
#cancerresearch #cancernews
Interested in cancer data science? Don't miss this informative webinar on September 10 where OICR's Junjun Zhang will present on WFPM - an #opensource tool that enables collaborative #bioinformatics workflows.
🧬🖥
Ready for the next installment of @theNCI Containers & Workflows Interest Group series? Join @OICR_news’ Jujun Zhang as he discusses the importance of reusable code packages for bioinformaticians & cancer researchers on Sep. 10: https://datascience.cancer.gov/news-events/events/wfpm-novel-workflow-package-manager-enable-collaborative-bioinformatics-workflow
Clinical trial breaks new ground on using immunotherapy for more cancer types
Guided by blood samples, researchers show that patients’ tumour genomic and immune landscape predict response to a common #immunotherapy http://ow.ly/zUVL50G6lrE
Congratulations to Dr. @MartinYaffe, Co-Director of OICR's Imaging Program, on being named a Fellow of The Royal Society of Canada in recognition of his work to develop digital mammography tools and other innovations. More on this research: https://twitter.com/RSCTheAcademies/status/1435235134727393285
Dr. Martin Yaffe - Ontario Institute for Cancer Research
Dr. Yaffe researches the development and improvement of imaging techniques for the earlier detection, diagnosis and treatment of cancer.
oicr.on.ca
Cancer research news roundup for the week of August 30 - September 3, 2021: http://ow.ly/Kxjs50G40G5
#cancerresearch #cancernews
Looking Ahead
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.